We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFTX
126
Definium Therapeutics
DFTX
$5.68B
$13M 0.21%
+686,162
New +$11.6M
PRAX icon
127
Praxis Precision Medicines
PRAX
$9.87B
$12.4M 0.21%
38,640
-28,460
-42% -$8.8M
ORIC icon
128
Oric Pharmaceuticals
ORIC
$1.4B
$12.1M 0.2%
953,451
+1,080
+0.1% +$12.3K
FIX icon
129
Comfort Systems
FIX
$55.9B
$12M 0.2%
8,807
+464
+6% +$589K
IVVD icon
130
Invivyd
IVVD
$268M
$11.8M 0.2%
9,071,995
+3,262,739
+56% +$5.99M
OCS icon
131
Oculis Holding
OCS
$686M
$11.4M 0.19%
+430,000
New +$11.4M
AXP icon
132
American Express
AXP
$226B
$11.1M 0.18%
36,964
-13,142
-26% -$4.41M
HD icon
133
Home Depot
HD
$328B
$11.1M 0.18%
34,187
+322
+1% +$117K
XOM icon
134
ExxonMobil
XOM
$641B
$10.9M 0.18%
63,494
+1,190
+2% +$174K
NEE icon
135
NextEra Energy
NEE
$172B
$10.7M 0.18%
115,514
+15,269
+15% +$1.36M
LAD icon
136
Lithia Motors
LAD
$8.17B
$10.6M 0.18%
42,568
-113,806
-73% -$33.8M
LITE icon
137
Lumentum
LITE
$83.7B
$10.4M 0.17%
14,871
+9,914
+200% +$5.45M
TTAN
138
ServiceTitan Inc
TTAN
$9.42B
$10.3M 0.17%
162,821
-15,795
-9% -$1.22M
LIN icon
139
Linde
LIN
$225B
$10.3M 0.17%
20,652
-626
-3% -$295K
AMGN icon
140
Amgen
AMGN
$234B
$10M 0.17%
28,647
+275
+1% +$98K
MDT icon
141
Medtronic
MDT
$116B
$9.79M 0.16%
113,734
+1,470
+1% +$141K
DRUG
142
Bright Minds Biosciences
DRUG
$717M
$9.49M 0.16%
130,013
+27,000
+26% +$2.17M
CSTL icon
143
Castle Biosciences
CSTL
$1.02B
$9.49M 0.16%
386,425
+81,425
+27% +$2.67M
CRWD icon
144
CrowdStrike
CRWD
$218B
$9.25M 0.15%
95,168
+5,400
+6% +$572K
AKTS
145
Aktis Oncology
AKTS
$1.45B
$9.07M 0.15%
+507,000
New +$9.84M
COHR icon
146
Coherent
COHR
$56.6B
$8.81M 0.15%
37,021
+28,061
+313% +$6.43M
STX icon
147
Seagate
STX
$192B
$8.38M 0.14%
21,647
+20,217
+1,414% +$7.71M
FLEX icon
148
Flex
FLEX
$42.1B
$8.24M 0.14%
127,902
-92,608
-42% -$5.92M
CRVS icon
149
Corvus Pharmaceuticals
CRVS
$1.21B
$8.05M 0.13%
+550,000
New +$8.78M
CAT icon
150
Caterpillar
CAT
$373B
$7.96M 0.13%
11,799
-248
-2% -$172K
4 5
6
7 8

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.